Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Drug Metabolism Reviews|April 18, 2013
Cytochrome P450 pharmacogenetics in African populationsMarco Alessandrini, Sahle Asfaha, Tyren Mark Dodgen, et al.
The Lancet. HIV|October 14, 2023
Haematopoietic stem-cell transplantation in an HIV endemic area: time to consider donors exposed to or living with HIVCandice Laverne Hendricks, Juanita Mellet, Chrisna Durandt, et al.
Frontiers in Immunology|July 27, 2023
Consequences of HIV infection in the bone marrow nicheCandice Lee Herd, Juanita Mellet, Tsungai Mashingaidze, et al.
Journal of Cellular and Molecular Medicine|April 28, 2025
Antiretroviral-Induced Toxicity in Umbilical Cord Blood-Derived Haematopoietic Stem/Progenitor CellsCandice Laverne Hendricks, Andrea Ellero, Juanita Mellet, et al.
Advances in Experimental Medicine and Biology|November 16, 2017
Cancer Stem Cells in Head and Neck Carcinomas: Identification and Possible Therapeutic ImplicationsElize Wolmarans, Sonja C Boy, Sulette Nel, et al.
Molecular Genetics & Genomic Medicine|August 27, 2022
Elucidation of repeat motifs R1- and R2-related TRIOBP variants in autosomal recessive nonsyndromic hearing loss DFNB28 among indigenous South African individualsRosemary Ida Kabahuma, Wolf-Dieter Schubert, Christiaan Labuschagne, et al.
Burns : Journal of the International Society for Burn Injuries|August 15, 2006
Progressive tissue injury in burns is reduced by rNAPc2Ajay L Mahajan, Xavier Tenorio, Michael Sean Pepper, et al.
Frontiers in Oncology|February 11, 2022
The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating CellsVictoria Damerell, Melvin Anyasi Ambele, Shanel Salisbury, et al.
Genes|March 6, 2021
Spectrum of <i>MYO7A</i> Mutations in an Indigenous South African Population Further Elucidates the Nonsyndromic Autosomal Recessive Phenotype of DFNB2 to Include Both Homozygous and Compound Heterozygous MutationsRosemary Ida Kabahuma, Wolf-Dieter Schubert, Christiaan Labuschagne, et al.
Stem Cell Research|April 27, 2017
Targeting the aryl hydrocarbon receptor nuclear translocator complex with DMOG and Stemregenin 1 improves primitive hematopoietic stem cell expansionCarlo Stephan Jackson, Chrisna Durandt, Ilse Janse van Rensburg, et al.
Pageof 3